Table 2. [Assignment of likely G6PD Phenotype based on Genotype/Diplotype (CPIC 2014)]. - Medical Genetics Summaries

Warning: The NCBI web site requires JavaScript to function. more...

Table 2.

Assignment of likely G6PD Phenotype based on Genotype/Diplotype (CPIC 2014)

Likely phenotype	Definition	Genotype	WHO class for G6PD variants^a	Example of diplotype^b
Normal	Very mild or no enzyme deficiency (less than 60% of normal enzyme levels)	A male who has a nondeficient (class IV) allele	IV	B, Sao Boria
Normal		A female who has 2 nondeficient (class IV) alleles	IV/IV	B/B, B/Sao Boria
Deficient	Less than 10–60% of normal enzyme activity	A male who has a deficient (class II–III) allele	II, III	A–, Orissa, Kalyan-Kerala, Mediterranean, Canton, Chatham
Deficient	Less than 10–60% of normal enzyme activity	A female who has 2 deficient (class II–III variants) alleles	II/II, II/III, III/III	A–/A–, A–/Orissa, Orissa/Kalyan-Kerala, Mediterranean/Mediterranean, Chatham/ Mediterranean, Canton/Viangchan
Deficient with CNSHA	Severe enzyme deficiency (<10% activity) and associated with CNHSA	A male who has a class I allele	I	Bangkok, Villeurbanne
Deficient with CNSHA		A female who has 2 deficient (class I variants) alleles	I/I	Bangkok/Bangkok, Bangkok/Villeurbanne
Variable^c	Normal or deficient enzyme activity^c	A female who has one nondeficient (class IV) and one deficient (class I–III variants) allele	IV/I, IV/II, IV/III	B/A–, B/Mediterranean, B/Bangkok

: CNSHA, chronic nonspherocytic hemolytic anemia
: WHO, World Health Organization
^a: WHO classifications (from ref. 14, other details from ref. 17, from (33)). Class I variants are extremely rare; the distinction between class II and III variants is not clear, and the “class V” very high activity variant has been reported in only a single case. Therefore, almost all individuals will have class II, III, or IV alleles. It should be noted that the class of a variant may have been assigned only by the clinical manifestations of an individual in which the variant was subsequently identified.
^b: Due to the large number of G6PD variants, many other diplotypes may be possible besides those given as examples here; see Supplementary Table S1 online for a more comprehensive list of variant alleles with their assigned WHO class (33). For HGVS terms, please see the Nomenclature table below.
^c: Due to X-linked mosaicism, females heterozygous for one nondeficient (class IV) and one deficient (class I–III variants) allele may display a normal or a deficient phenotype. It is therefore difficult to predict the phenotype of these individuals (Supplementary Material online (G6PD heterozygotes)) (33).
: This CPIC table is adapted from (33).

From: Tafenoquine Therapy and G6PD Genotype

Medical Genetics Summaries [Internet].

Pratt VM, Scott SA, Pirmohamed M, et al., editors.

Bethesda (MD): National Center for Biotechnology Information (US); 2012-.

All Medical Genetics Summaries content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license which permits copying, distribution, and adaptation of the work, provided the original work is properly cited and any changes from the original work are properly indicated. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.